XML 80 R54.htm IDEA: XBRL DOCUMENT v3.22.4
Equity Method Investments - Additional Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Jul. 31, 2019
Schedule Of Equity Method Investments [Line Items]          
Revenue recognized $ (120,000,000.0) $ (18,600,000)      
Loss from equity method investment (10,600,000) (6,900,000) $ (4,100,000)    
Equity method investments 0        
Deferred revenue 623,700,000 740,500,000 45,100,000    
Operating expenses 394,600,000 242,000,000.0 146,700,000    
Oerth          
Schedule Of Equity Method Investments [Line Items]          
Operating expenses 22,900,000 14,300,000 8,300,000    
Net loss 22,900,000 $ 14,300,000 $ 8,300,000    
Oerth          
Schedule Of Equity Method Investments [Line Items]          
Equity interest 49,400,000        
Future grant of incentive units to service providers, percentage         15.00%
Revenue recognized       $ 24,700,000  
Loss from equity method investment       (24,700,000)  
Equity method investments       $ 0  
Deferred revenue $ 24,700,000        
Bayer LP | Oerth          
Schedule Of Equity Method Investments [Line Items]          
Equity interest         $ 56,000,000
Ownership interest, percentage 46.50% 48.40% 49.40%   50.00%